Fibrin gel for controlled release of TGFbeta and uses thereof

Details for Australian Patent Application No. 2008206052 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Helgerson, Sam L.; Catelas, Isabelle

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008206052

PCT Pub. Number WO2008/089466

Priority 60/934,457 13.06.07 US; 60/881,452 18.01.07 US

Filing date 18 January 2008

Wipo publication date 24 July 2008

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/089466 Priority application(s): WO2008/089466

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206058-Animal management system including radio animal tag and additional transceiver(s)

2008206051-Gene polymorphisms as sex-specific predictors in cancer therapy